In pg 12/22, omit "who" in: Patient Tolerance for Risk: Patients "who" are willing to take the risk of having the device implanted even for a small probability of benefit because they have no other treatment options and their symptoms are severe
In pgs 14 and 15/22, add "Approval/Non-Approval Considerations:" header, to the last paragraphs of Examples 2 and 3.
In the spirit of transparency and to allow a better understanding of FDA's decision making process, it may be useful to add the file number reference for the different examples of Section 5.2, Examples Based on Actual FDA Benefit-Risk Determinations.
Francisco Martinez Murillo - Comment
This is comment on Notice
Draft Guidance for Industry and Staff; Availability: Factors To Consider When Making Benefit-Risk Determinations in Medical Device Premarket Review
View Comment
Related Comments
View AllPublic Submission Posted: 09/27/2011 ID: FDA-2011-D-0577-0003
Nov 14,2011 11:59 PM ET
Public Submission Posted: 11/04/2011 ID: FDA-2011-D-0577-0004
Nov 14,2011 11:59 PM ET
Public Submission Posted: 12/16/2011 ID: FDA-2011-D-0577-0005
Nov 14,2011 11:59 PM ET
Public Submission Posted: 12/16/2011 ID: FDA-2011-D-0577-0006
Nov 14,2011 11:59 PM ET
Public Submission Posted: 12/16/2011 ID: FDA-2011-D-0577-0007
Nov 14,2011 11:59 PM ET